ZielBio is a biotechnology company that identifies novel disease targets and develops therapeutic interventions to improve patient outcomes. The company offers Zielfind, a drug discovery platform that combines functional screening with large content data analytics to identify high value targets. It has a pipeline of therapies and targets, including ZB131, a cancer target identified through Zielfind.
|Employees (est.) (Oct 2019)||10|
ZielBio total Funding
ZielBio latest funding size
Time since last funding
|5 months ago|
|Partners Innovation Fund, Morningside Venture Partners|
When was ZielBio founded?
ZielBio was founded in 2012.
Who are ZielBio key executives?
ZielBio's key executives are Kimberly A. Kelly, Colin Rolph and Julien Dimastromatteo.
How many employees does ZielBio have?
ZielBio has 10 employees.
Who are ZielBio competitors?
Competitors of ZielBio include Genome Biologics, Genesis Therapeutics and Redesign Science.
Where is ZielBio headquarters?
ZielBio headquarters is located at 315 Old Ivy Way #301, Charlottesville.
Where are ZielBio offices?
ZielBio has an office in Charlottesville.
How many offices does ZielBio have?
ZielBio has 1 office.
Receive alerts for 300+ data fields across thousands of companies